Clinical outcomes in patients with atrial fibrillation treated with DOACs in a specialized anticoagulation center: Critical appraisal of real-world data.

Clinical outcomes in patients with atrial fibrillation treated with DOACs in a specialized anticoagulation center: Critical appraisal of real-world data.

<h4>Aims</h4>Direct oral anticoagulants (DOAC) are progressively replacing vitamin K antagonists in the prevention of thromboembolism in patients with atrial fibrillation. However, their real-world clinical outcomes appear to be contradictory, with some studies reporting fewer and others...

Full description

Bibliographic Details
Main Authors: Carla Moret, René Acosta-Isaac, Sergi Mojal, Mariana Corrochano, Blanca Jiménez, Melania Plaza, Juan Carlos Souto
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0279297

Internet

https://doi.org/10.1371/journal.pone.0279297

Similar Items